Trials / Sponsors / Aduro Biotech, Inc.

Aduro Biotech, Inc.

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Safety of ADU-1604 in Adults With Metastatic Melanoma Metastatic Melanoma	Phase 1	2018-11-08
Terminated	Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma	Phase 2	2017-08-14
Terminated	Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM) Malignant Pleural Mesothelioma	Phase 2	2017-05-31
Terminated	Study of Personalized Immunotherapy in Adults With Metastatic Colorectal Cancer Colorectal Neoplasms	Phase 1	2017-05-02
Terminated	Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer Platinum-resistant Ovarian Cancer, Platinum-resistant Fallopian Cancer, Platinum-resistant Peritoneal Cancer	Phase 1 / Phase 2	2016-03-08
Completed	Safety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural Malignant Pleural Mesothelioma	Phase 1	2014-09-03
Completed	Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting 2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer	Phase 2	2014-02-05
Completed	Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer Metastatic Pancreatic Cancer	Phase 2	2011-09-21